Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III – IV congestive heart failure
Freudenberger, Ronald S, Schwarz Jr, Richard P, Brown, Joanne, Moore, Alan, Mann, Douglas, Givertz, Michael M, Colucci, Wilson S, Hare, Joshua MVolume:
13
Language:
english
Journal:
Expert Opinion on Investigational Drugs
DOI:
10.1517/13543784.13.11.1509
Date:
November, 2004
File:
PDF, 99 KB
english, 2004